We are monitoring the impact of COVID-19 on Europe Insulin Delivery Devices Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 228
Share on
Share on

European Insulin Delivery Devices Market Analysis - By Type, Application, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) – Industry Analysis on Size, Share, Trends, Growth, Forecast (2020 to 2025)

Pulished: February, 2020
ID: 228
Pages: 138

Europe Insulin Delivery Devices Market Size (2020 to 2025)

As per our report, the size of the insulin delivery devices market in Europe is estimated to value USD 4.26 billion by 2025 from USD 3.12 billion in 2019, registering a growth rate of 6.40% from 2020 to 2025.

An insulin delivery device is a part of medical tools that help enter insulin into the human body to cure diabetes.

Europe's insulin delivery devices market is majorly driven by the growing diabetes patients and government support through funding and development in healthcare facilities. There are 67 million people caused by diabetes due to changing lifestyles, obesity, and consume an unhealthy diet. According to the World Health Organization (WHO), an estimated 30-70% of adults are overweight, while it affects 10-30% of adults in Europe. The government has taken the initiative to arrange new programs that create awareness about delivery devices. 

However, limited usage of the insulin pump, restricted access to people's healthcare, and availability of high-cost management in Europe are majorly challenging the insulin delivery devices market. Sometimes the abnormal dose of insulin is very harmful to patients is hindering the insulin delivery market in Europe. Also, the devices are not used for children who less than 18 years. The number of insulin delivery devices uses short-acting insulin; it is a big challenge for the insulin delivery devices market.

This research report segmented and sub-segmented into the following categories:

  • By Type: Insulin Syringes, Insulin Pens, Insulin Pen Needles, Insulin Pumps, And Insulin Jet Injectors.
  • By Application: Type I Diabetes and Type II Diabetes.
  • By Country: The United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and the Rest of Europe.

Regional Analysis

In Europe, Germany was leading the European insulin delivery devices market in 2019. Due to technological developments and the Government of Germany taken initiatives to create awareness of insulin delivery devices among people are the factors primarily driving the growth of the market in this country. In 2019, Medtronic had an agreement with Germany statutory health insurance to provide MiniMed 670G hybrid closed-loop insulin pump for the treatment of type 1 diabetes.

UK insulin delivery devices market is expected to grow at the fastest growth rate during the forecast period. Around 4 million people have type 1 diabetes, and 549000 people diagnosed in the UK in 2019. Recently, Insulet Corp has developed a new Omnipol DASH insulin pump in the UK that can manage insulin instead of a daily multiple injector system. 

An increasing geriatric population and type 1 diabetes patients in France enhance the demand for insulin delivery devices. The French start-up more funding in research and development activities to develop a hybrid loop system for the management of glucose levels and maintain type 1 diabetes.

Italy has more than 2 million patients with type 2 diabetes, and they accelerate the growth of insulin delivery devices in the market. National congress Italian society metabolism diabetes obesity has announced to introduce a V-Go wearable insulin delivery device for the treatment of type 2 diabetes.

Key players operating in the Europe Insulin Delivery Devices Market profiled in this report are Becton, Dickinson, and Company (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland) and Biodel Inc. (U.S.).

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Introduction                                                               

                5.2 Type                                                              

                                5.2.1 Introduction                                           

                                5.2.2 Insulin Syringes                                     

                                5.2.3 Insulin Pens                                            

                                5.2.4 Insulin Pen Needles                                            

                                5.2.5 Insulin Pumps                                        

                                5.2.6 Insulin Jet Injectors                                             

                5.3 Application                                                 

                                5.3.1 Introduction                                           

                                5.3.2 Type I Diabetes                                     

                                5.3.3 Type II Diabetes                                    

6. Geographical Analysis                                                                              

                                6.2.1 Introduction                                           

                                6.2.2 U.K                                             

                                6.2.3 Spain                                         

                                6.2.4 Germany                                 

                                6.2.5 Italy                                            

                                6.2.6 France                                       

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Sanofi (France)                                                         

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Novo Nordisk A/S (Denmark)                                                             

                8.3 Eli Lilly and Company (U.S.)                                                  

                8.4 Biocon Ltd. (India)                                                   

                8.5 Julphar (U.A.E.)                                                        

                8.6 Ypsomed AG (Switzerland)                                                  

                8.7 Becton, Dickinson and Company (U.S.)                                                          

                8.8 Wockhardt Ltd. (India)                                                           

                8.9 B. Braun Meselgen AG (Switzerland)                                                              

                8.10 Biodel Inc. (U.S.)                                                    

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Insulin Delivery Devices Market, By Region, From 2020 to 2025 (USD Million)
  2. Europe Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  3. Europe Insulin Syringes Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe Insulin Pens Market, By Region, From 2020 to 2025 (USD Million)
  5. Europe Insulin Pen Needles Market, By Region, From 2020 to 2025 (USD Million)
  6. Europe Insulin Pumps Market, By Region, From 2020 to 2025 (USD Million)
  7. Europe Insulin Jet Injectors Market, By Region, From 2020 to 2025 (USD Million)
  8. Europe Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)
  9. Europe Type I Diabetes of Insulin Delivery Devices Market, By Region, From 2020 to 2025 (USD Million)
  10. Europe Type II Diabetes of Insulin Delivery Devices Market, By Region, From 2020 to 2025 (USD Million)
  11. U.K Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  12. U.K Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)
  13. Spain Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  14. Spain Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)
  15. Germany Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  16. Germany Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)
  17. Italy Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  18. Italy Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)
  19. France Insulin Delivery Devices Market, By Type, From 2020 to 2025 (USD Million)
  20. France Insulin Delivery Devices Market, By Application, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample